-

Viz.ai Wins Comparably Awards for Best Place to Work for Third Consecutive Year

Healthcare AI leader recognized for its outlook, leadership and career growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has been named a Best Place to Work by Comparably, a leading workplace culture and compensation monitoring employee review platform, for three consecutive years. The Company received three Comparably Best Place to Work Awards in 2024 for Best Company Outlook, Best Leadership Teams and Best Career Growth.

"We are thrilled that Viz.ai has been recognized with three distinguished awards for our exceptional workplace culture. These accolades reflect the dedication and hard work of our team as well as our unwavering commitment to expanding access to life-saving treatments," said Dawn Sprague, vice president of People at Viz.ai. "Our primary goal is to cultivate an environment where everyone can thrive and develop, and we remain dedicated to investing in a culture that supports each individual's ambitions and personal growth."

Viz.ai ranks in the top 5% of other companies on Comparably with 201-500 employees for overall company culture. Out of 492 Viz.ai employee reviews, 93% were positive. In an anonymous survey, one Viz.ai team member shared, “Viz provides a dynamic and empowering work environment. The flexibility with work hours and wellness days foster a healthy work-life balance, and the remote structure encourages autonomy. Overall, it's been an enriching experience that values individual contributions while promoting adaptability.”

Comparably recognizes exceptional companies with the Best Place to Work Awards based on anonymous employee ratings about their workplaces over a 12-month period. The final data set was compiled from over 20 million ratings across 70,000 companies.

To learn about opportunities to join Viz.ai, please visit https://www.viz.ai/careers.

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,600+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai OneTM is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Media
Olivia Schlabach
olivia.schlabach@finnpartners.com

Viz.ai


Release Versions

Contacts

Media
Olivia Schlabach
olivia.schlabach@finnpartners.com

Social Media Profiles
More News From Viz.ai

New Data Show Viz.ai’s AI-Enabled ECG Screening Increases Detection and Accelerates Diagnosis of Hypertrophic Cardiomyopathy

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how Viz HCM enables faster, accurate detection of hypertrophic cardiomyopathy (HCM), to help ensure that more patients are identified. Two studies, which will be presented at the American Heart Association (AHA) Scientific Sessions 2025, show Viz.ai’s real-world ability to identify more patients with HCM years earlier than current...

Viz.ai Launches Viz Assist: The First Multimodal AI Agent Platform for Faster Treatment and Better Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz Assist™, a suite of autonomous AI agents that significantly enhance how care teams identify, prioritize, and act on critical patient data.1 Viz Assist marks a major step forward in Viz.ai’s mission to use technology to reduce time to treatment and improve patient outcomes. Viz Assist incorporates inputs from ambient listening and the electronic...

Viz.ai Launches Viz ACS™ to Accelerate Treatment for Heart Attack and Reduce Unnecessary Activations

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz ACS, a new solution in the Viz Cardio™ Suite. Designed to unite the acute coronary syndrome (ACS) care team on a single platform, Viz ACS provides Emergency Department (ED) physicians and cardiologists with the same high-quality ECGs and patient data in real time. This streamlined workflow can help improve communication, speeds treatment, and re...
Back to Newsroom